|
KMID : 1011820200610000003
|
|
Investigative and Clinical Urology
2020 Volume.61 No. 0 p.3 ~ p.7
|
|
|
The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
|
|
Parker Daniel C.
Cookson Michael S.
|
|
|
Abstract
|
|
|
|
Metastatic prostate cancer is a heterogeneous disease entity. Men without prior androgen deprivation therapy exposure are termed metastatic castration sensitive prostate cancer (mCSPC). The goal of this article is to update the reader on the rapidly changing landscape of treatment for men with mCSPC. Along with the options available to the clinician for treatment of men with mCSPC, the care of these patients has evolved into a multi-disciplinary field with expanding roles for medical, urologic, and radiation oncologists.
|
|
|
KEYWORD
|
|
|
Classification, Disease management, Drug therapy, Prostatic neoplasms, Therapeutics
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|